| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 12/17/2009 | US20090311179 Selective Targeting of Apoptotic Cells |
| 12/17/2009 | CA2727866A1 Novel peptide adjuvant for influenza vaccination |
| 12/17/2009 | CA2727780A1 Novel potassium channel blockers and uses thereof |
| 12/17/2009 | CA2727315A1 Pyrrolo [2, 3-c] pyridine derivatives as p38 kinase inhibiting agents |
| 12/17/2009 | CA2725530A1 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors |
| 12/17/2009 | CA2720365A1 Bcr-complex-specific antibodies and methods of using same |
| 12/16/2009 | EP2133693A1 Evaluation method and screening method for substance having action of activating/suppressing innate immunity, agent and food product for activating/suppressing innate immune mechanism and method for producing the same |
| 12/16/2009 | EP2133348A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 12/16/2009 | EP2133335A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 12/16/2009 | EP2133326A1 Novel pseudoglycolipid and use thereof |
| 12/16/2009 | EP2133098A1 G-CSF conjugates |
| 12/16/2009 | EP2132230A2 Apoptotic anti-ige antibodies binding the membrane-bound ige |
| 12/16/2009 | EP2132226A2 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized ldl receptor-1 (lox-1) |
| 12/16/2009 | EP2132209A1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators |
| 12/16/2009 | EP2131866A2 Dual acting prodrugs |
| 12/16/2009 | EP2131856A2 Compositions and methods for the prevention and treatment of autoimmune conditions |
| 12/16/2009 | EP1904057B1 Hydroquinone ansamycins in the treatment of gastrointestinal stromal tumors |
| 12/16/2009 | EP1434603B1 Method of treatment using ligand-immunogen conjugates |
| 12/16/2009 | EP1287147B1 Immunotoxin fusion proteins and means for expression thereof |
| 12/16/2009 | CN101605814A Engineered anti-TSLP antibody |
| 12/16/2009 | CN101605772A Novel methylated catechin and composition containing the same |
| 12/16/2009 | CN101605759A 1-benzenesulfonyl-1H-indole derivatives as inhibitors of CCR9 activity |
| 12/16/2009 | CN101605557A Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases |
| 12/16/2009 | CN101605556A TRKB agonists for treating autoimmune disorders |
| 12/16/2009 | CN101605544A CRTH2 antagonists |
| 12/16/2009 | CN101602807A Mammalian cytokines, reagent and method thereof |
| 12/16/2009 | CN101602763A Preparation method of oxymatrine |
| 12/16/2009 | CN101602731A Metalloproteinase inhibitors |
| 12/16/2009 | CN101601861A Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component |
| 12/16/2009 | CN101601835A Tumor post-operation treating medicine and preparation method thereof |
| 12/16/2009 | CN101601812A Nutrient capable of strengthening human immunity and protecting cells of heat, brain, liver, kidney, stomach and intestine |
| 12/16/2009 | CN101601793A Manufacturing method of qi-blood recovery medicine |
| 12/16/2009 | CN101601737A Microemulsion of total glucosides of paeony and active components |
| 12/16/2009 | CN101601727A Thrombus-dredging wine drug |
| 12/16/2009 | CN101601688A A pig placental article and preparation thereof |
| 12/16/2009 | CN101601637A Pumelo leaf extract and skin cream using same |
| 12/16/2009 | CN100569944C Production of polyketides and other natural products |
| 12/16/2009 | CN100569936C Acanthopanax-root wine and its production method |
| 12/16/2009 | CN100569796C Immune modulating peptide |
| 12/16/2009 | CN100569287C Immunoglobulin for dog intravenous injection, its preparing method and the formulation thereof |
| 12/16/2009 | CN100569286C Attenuated strains of vibrio cholerae with freeze-dry type and modified biological security for orally inoculability |
| 12/16/2009 | CN100569285C Application of immunological stimulant compound in preparing fish immunity preparation |
| 12/16/2009 | CN100569266C Chinese medicine health care food |
| 12/16/2009 | CN100569254C External-applied chrisma for treating infantile eczematization |
| 12/16/2009 | CN100569113C Health-care food having functions of oxidation resisting and immunity improving and preparation method thereof |
| 12/16/2009 | CN100569112C Food |
| 12/15/2009 | US7632935 DNA encoding a mast cell-derived membrane protein |
| 12/15/2009 | US7632870 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
| 12/15/2009 | US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 12/15/2009 | US7632817 Antibodies against exogeneous protein; epitopes different from those detected by antibodies; myasthenia gravis; infertility; gene therapy |
| 12/15/2009 | US7632495 Administering fibrinogen like protein 2 (fgl2) or a nucleic acid encoding it; preventing graft versus host rejection, autoimmune disease, and allergies; T-cell proliferation inhibitors |
| 12/15/2009 | CA2481459C A pharmaceutical composition for treating rheumatism and the preparation thereof |
| 12/15/2009 | CA2424884C Substituted (e)-styryl benzylsulfones for treating proliferative disorders |
| 12/15/2009 | CA2398908C Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 12/15/2009 | CA2393437C Exo-s-mecamylamine formulation and use in treatment |
| 12/15/2009 | CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 12/15/2009 | CA2345138C Polymer conjugates of interferon beta-1a and their uses |
| 12/15/2009 | CA2333125C Alpha emitting constructs and uses thereof |
| 12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
| 12/10/2009 | WO2009149382A2 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells |
| 12/10/2009 | WO2009148599A1 Pyrrole compunds that modulate hsp90 activity |
| 12/10/2009 | WO2009148299A1 Method to stimulate immune function and regeneration |
| 12/10/2009 | WO2009148137A1 Nucleic acid capable of controlling degranulation of mast cell |
| 12/10/2009 | WO2009147187A1 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases |
| 12/10/2009 | WO2009146523A1 Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| 12/10/2009 | WO2009126688A3 Novel compositions and methods for the treatment of immune related diseases |
| 12/10/2009 | WO2009117736A3 Avian virus vaccines and uses thereof |
| 12/10/2009 | WO2009117640A3 Antibodies against interleukin-10 like cytokines and uses therefor |
| 12/10/2009 | WO2007096782A3 Compositions for disorders associated wtth metachromatic cell activation |
| 12/10/2009 | US20090306177 Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide Modification |
| 12/10/2009 | US20090306155 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases |
| 12/10/2009 | US20090306138 chemokine receptor antagonists, such as 1-{3-[3-(4-fluorophenoxy)pyrrolidine-1-yl]propyl}-3-(3-methoxyphenyl)-urea, used as antiinflammatory agents |
| 12/10/2009 | US20090306135 Stable amorphous fexofenadine hydrochloride |
| 12/10/2009 | US20090306104 Use of Lck inhibitors for treatment of immunologic diseases |
| 12/10/2009 | US20090306086 Compounds and methods for kinase modulation, and indications therefor |
| 12/10/2009 | US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 12/10/2009 | US20090306069 Azolidinone-vinyl fused-benzene derivatives |
| 12/10/2009 | US20090306045 Inhibition of Glycogen Synthase Kinase and Methods of Treating Autoimmune or Immune Inflammatory Disease |
| 12/10/2009 | US20090306041 Inhibitors of Bruton's tyrosine kinase |
| 12/10/2009 | US20090306017 Methods and compositions for modulation of innate immunity |
| 12/10/2009 | US20090306001 Novel amphiphilic derivatives of alpha-c-phenyl-n-tert-butylnitrone |
| 12/10/2009 | US20090305996 Use of non-digestable sacharides for giving an infant the best start after birth |
| 12/10/2009 | US20090305991 33 Human Secreted Proteins |
| 12/10/2009 | US20090305344 Chimeric alphavirus replicon particles |
| 12/10/2009 | US20090304799 Nanoemulsion influenza vaccine |
| 12/10/2009 | US20090304750 Novel prime-boost combinations of attenuated mycobacterium |
| 12/10/2009 | US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions |
| 12/10/2009 | US20090304744 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof |
| 12/10/2009 | US20090304740 Use in HIV vaccines; HIV envelope proteins modified to expose the CD4 binding region |
| 12/10/2009 | US20090304736 Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera |
| 12/10/2009 | US20090304735 Immunogenic Compositions |
| 12/10/2009 | US20090304727 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies |
| 12/10/2009 | US20090304723 Mono-and disaccharide derivatives |
| 12/10/2009 | US20090304718 Antibody Molecules Specific for Fibroblast Activation Protein and Immunoconjugates Containing Them |
| 12/10/2009 | US20090304709 Modulators of p-selectin glycoprotein ligand 1 |
| 12/10/2009 | US20090304708 Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin |
| 12/10/2009 | US20090304703 Compositions and methods for the diagnosis and treatment of immune disorders |
| 12/10/2009 | US20090304682 Multiple-variable dose regimen for treating TNFa-related disorders |
| 12/10/2009 | US20090304660 G-csf derivative for inducing immunological tolerance |